Skip to content
The Kids Research Institute Australia logo
Donate

Search

Showing results for "early lung health"

Vaccine acceptance: Science, policy, and practice in a ‘post-fact’ world

We must continue our efforts to promote vaccine acceptance and thus increase vaccination uptake, by fostering more effective vaccination communication

Association of maternal prenatal smoking GFI1-locus and cardio-metabolic phenotypes in 18,212 adults

Epigenetic changes at the GFI1 were linked to smoking exposure in-utero/in-adulthood and robustly associated with cardio-metabolic risk factors

Construct validity and responsiveness of the functional Tactile Object Recognition Test for children with cerebral palsy

The functional Tactile Object Recognition Test demonstrated preliminary construct validity, and was positively associated with an upper limb activity measure

How New and Expecting Fathers Engage With an App-Based Online Forum: Qualitative Analysis

These data show that fathers are prepared to use a breastfeeding-focused online forum in a variety of ways to facilitate social support

The Kids researchers share in $1.75m ACRF grant for cancer research

Three The Kids researchers are collaborating on a cancer research project that has been awarded a $1.75mill grant by the Australian Cancer Research Fund.

Environmental factors could trigger rise in type 1 diabetes

New research from Perth's Telethon Institute for Child Health Research has revealed an unexpected pattern in the rate and incidence of type 1 diabetes

Trial begins of first vaccine against Ross River Virus

Perth researchers are seeking volunteers to test the effectiveness of a vaccine against the debilitating Ross River Virus.

New vaccine promises fewer needles

Perth researchers are calling for help from Perth toddlers and their parents to participate in a new project that aims to reduce the number of injections

Childhood meningitis falls by 70%

The introduction of the Hib (Haemophilus influenzae type b) vaccine to the childhood immunisation schedule has resulted in a dramatic drop

A phase 3, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety and tolerability of V114 in healthy infants (PNEULINK)

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical